Alexion Pharmaceuticals Stock News

BCRX earnings call for the period ending June 30, 2020.

Alexion Announces Appointment of First Chief Diversity Officer

BOSTON--(BUSINESS WIRE)--Alexion Announces Appointment of First Chief Diversity Officer

Alexion Announces Appointment of First Chief Diversity Officer

Marching forward together, the previous decade saw equities and bonds rally right alongside each other. At the same time, there was a negative correlation of daily returns, limiting portfolio volatili

The biopharmaceutical industry has been one of the most resilient in dealing with the coronavirus pandemic.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and aut

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Dicerna announced that the Company approved the grant of inducement stock options of common stock and restricted stock units among seven employees.

Ante la escisión de autopartes Nemak, S&P Global Ratings colocó en revisión negativa las calificaciones crediticias de Alfa.

S&P Global Ratings colocó en revisión especial con implicaciones negativas las calificaciones crediticias del conglomerado industrial mexicano Alfa, luego que anunció en la víspera que prepara la

Intact Investment Management Inc. cut its stake in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 11.4% in the second quarter, according to the company in its most recent Form 13F filing wit

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and au

Mexico's Alfa said on Friday it plans to spin off the entirety of its remaining 75% stake in auto parts business Nemak , sending Alfa's shares surging 17% on the prospect that the conglomerate could s

ALXN earnings call for the period ending June 30, 2020.